How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) released its quarterly earnings results on Tuesday, August, 9th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of ($2.70) by $3.20. The business had revenue of $5.50 million for the quarter, compared to analysts' expectations of $5.38 million. Alliqua Biomedical had a negative trailing twelve-month return on equity of 71.73% and a negative net margin of 230.50%.

When did Alliqua Biomedical's stock split?

Alliqua Biomedical's stock reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Alliqua Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliqua Biomedical investors own include Palatin Technologies (PTN) , ContraVir Pharmaceuticals (CTRV) , Argos Therapeutics (ARGSQ) , Consolidated Water (CWCO) , Biopharmx (BPMX) , Ritter Pharmaceuticals (RTTR) , NVIDIA (NVDA) , OPKO Health (OPK) , Gilead Sciences (GILD) and Tonix Pharmaceuticals (TNXP) .

NASDAQ:ALQA

Alliqua Biomedical (ALQA) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free ALQA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $2.20
▼
$3.23
52-Week Range: N/A

Volume: 371,516 shs
Average Volume: 114,400 shs
Market Capitalization: $13.46 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Alliqua Biomedical alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Alliqua Biomedical Stock (NASDAQ:ALQA)

Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ALQA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ALQA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliqua Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/09/2016
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & Medical Instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:ALQA
CUSIP: N/A
CIK: 1054274
Web: www.alliqua.com
Phone: 215-702-8550
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,420,000.00
Net Margins: -230.50%
Pretax Margin: N/A
Return on Equity: -71.73%
Return on Assets: -55.23%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 8.28
Quick Ratio: 8.17

Sales & Book Value

Annual Sales: $2.22 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.65 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 5,010,000
Free Float: N/A
Market Cap: $13.46 million
Optionable: Not Optionable
Beta: 2.03

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. David Ian Johnson (Age 61)
Pres, CEO, Principal Financial Officer & Director
Dr. Phillip D. Forman M.D. (Age 60)
DPM, Exec. VP of Clinical Affairs
Mr. Joseph M. Warusz (Age 63)
CFO, Treasurer & Sec.

Key Competitors

View All Competitors

ALQA Stock Analysis - Frequently Asked Questions

How were Alliqua Biomedical's earnings last quarter?: Alliqua Biomedical Inc (NASDAQ:ALQA) released its quarterly earnings results on Tuesday, August, 9th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of ($2.70) by $3.20. The business had revenue of $5.50 million for the quarter, compared to analysts' expectations of $5.38 million. Alliqua Biomedical had a negative trailing twelve-month return on equity of 71.73% and a negative net margin of 230.50%.
When did Alliqua Biomedical's stock split?: Alliqua Biomedical's stock reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
What other stocks do shareholders of Alliqua Biomedical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alliqua Biomedical investors own include Palatin Technologies (PTN), ContraVir Pharmaceuticals (CTRV), Argos Therapeutics (ARGSQ), Consolidated Water (CWCO), Biopharmx (BPMX), Ritter Pharmaceuticals (RTTR), NVIDIA (NVDA), OPKO Health (OPK), Gilead Sciences (GILD) and Tonix Pharmaceuticals (TNXP).

This page (NASDAQ:ALQA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alliqua Biomedical (ALQA) Stock Price, News & Analysis

About Alliqua Biomedical Stock (NASDAQ:ALQA)

ALQA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ALQA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info